Radiotherapy Positioning Devices Market: Drivers and Restrains

According to World Health Organization, it is estimated that by 2030, about 23.6 million new cases of cancer will prevail worldwide. Governmental guidelines from American Society of Clinical Oncology and National Comprehensive Cancer Network (NCCN /ASCO) are providing help to healthcare professionals in the management and treatment of cancer patients.

In April 2016, the U.S. Government allocated US$ 5.2 Bn for the National Cancer Institute (NCI), a federal government agency, for cancer research and training. Good ergonomic design of the radiotherapy positioning devices will reduce the risk injuries among healthcare professionals, increasing workflow efficiencies, accurate delivery of prescribed radiation doses and others are some of the factors boosting the radiotherapy positioning devices market.

The budget increased by 5.3% as compared to the previous year. Insurance coverage and reimbursement issues, big companies are investing heavily in the cancer therapeutics and accessory devices used during the treatment process involving both time and money, and there is no guarantee that the product will get coverage, radiation risk to healthcare professionals and patients are some factors that may decline the growth of radiotherapy positioning devices

The radiotherapy positioning devices market is segmented into product type and end user. Based on the Product type, the global Radiotherapy Positioning Devices market is segmented into head, neck, and brain immobilization devices, thorax and breast immobilization device, pelvic immobilization devices and others. The positioning and immobilization devices provide small treatment volume, higher controlled doses and précised treatment options with higher cure rate. 

Based on the end user, the market is segmented into the hospital, ambulatory surgical centres, and cancer research institutes. The rise in cancer patient population, funding by the governmental bodies, focus on acquisition and merger by various key manufacturers is attributed towards the growth of radiotherapy positioning devices market.